EcoDrugPlus

Endothelin Converting Enzyme 1

Ensembl ID : ENSLACG00000017425
Gene Symbol: ECE1
4 Cross references
229 Possible Orthologues:

Endothelin Receptor Type A

Ensembl ID : ENSLACG00000005414
Gene Symbol: EDNRA
4 Cross references
265 Possible Orthologues:

Endothelin Receptor Type B

Ensembl ID : ENSLACG00000013169
Gene Symbol: EDNRB
4 Cross references
264 Possible Orthologues:

Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit

Ensembl ID : ENSLACG00000009785
Gene Symbol: EZH2
2 Cross references
224 Possible Orthologues:

Eph Receptor A3

Ensembl ID : ENSLACG00000006618
Gene Symbol: EPHA3
1 Cross references
214 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 2

Ensembl ID : ENSLACG00000014945
Gene Symbol: ERBB2
3 Cross references
200 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSLACG00000001321
Gene Symbol: ERBB3
1 Cross references
283 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSLACG00000003856
Gene Symbol: ERBB4
4 Cross references
236 Possible Orthologues:

Estrogen Receptor 2

Ensembl ID : ENSLACG00000016807
Gene Symbol: ESR2
4 Cross references
274 Possible Orthologues:

Estrogen Related Receptor Gamma

Ensembl ID : ENSLACG00000010017
Gene Symbol: ESRRG
2 Cross references
272 Possible Orthologues:

Exportin 1

Ensembl ID : ENSLACG00000018213
Gene Symbol: XPO1
2 Cross references
307 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSLACG00000007627
Gene Symbol: FDFT1
3 Cross references
220 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).